中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/29 | 4,153 | 4,185 | 4,136 | 4,154 | +4 | +0.1% | 2,277,900 |
2023/06/28 | 4,137 | 4,162 | 4,085 | 4,150 | -16 | -0.4% | 4,008,400 |
2023/06/27 | 4,175 | 4,220 | 4,124 | 4,166 | -34 | -0.8% | 1,889,900 |
2023/06/26 | 4,151 | 4,218 | 4,130 | 4,200 | -21 | -0.5% | 1,969,400 |
2023/06/23 | 4,284 | 4,299 | 4,200 | 4,221 | -43 | -1% | 1,876,200 |
2023/06/22 | 4,324 | 4,329 | 4,256 | 4,264 | -40 | -0.9% | 1,819,100 |
2023/06/21 | 4,315 | 4,352 | 4,270 | 4,304 | +4 | +0.1% | 2,715,700 |
2023/06/20 | 4,225 | 4,300 | 4,185 | 4,300 | +63 | +1.5% | 2,346,600 |
2023/06/19 | 4,263 | 4,282 | 4,217 | 4,237 | -6 | -0.1% | 2,361,500 |
2023/06/16 | 4,150 | 4,249 | 4,127 | 4,243 | +97 | +2.3% | 4,208,800 |
2023/06/15 | 4,159 | 4,199 | 4,143 | 4,146 | -16 | -0.4% | 2,856,300 |
2023/06/14 | 4,178 | 4,178 | 4,123 | 4,162 | +9 | +0.2% | 2,947,700 |
2023/06/13 | 4,084 | 4,155 | 4,057 | 4,153 | +104 | +2.6% | 3,112,400 |
2023/06/12 | 4,001 | 4,065 | 3,999 | 4,049 | +84 | +2.1% | 1,926,800 |
2023/06/09 | 3,950 | 4,013 | 3,946 | 3,965 | +100 | +2.6% | 4,098,300 |
2023/06/08 | 3,921 | 3,951 | 3,839 | 3,865 | -106 | -2.7% | 2,674,400 |
2023/06/07 | 4,040 | 4,068 | 3,971 | 3,971 | -89 | -2.2% | 3,647,500 |
2023/06/06 | 3,962 | 4,064 | 3,955 | 4,060 | +137 | +3.5% | 3,257,700 |
2023/06/05 | 3,915 | 3,923 | 3,873 | 3,923 | +42 | +1.1% | 2,151,000 |
2023/06/02 | 3,848 | 3,886 | 3,829 | 3,881 | +69 | +1.8% | 2,291,400 |
2023/06/01 | 3,781 | 3,812 | 3,758 | 3,812 | +57 | +1.5% | 1,971,800 |
2023/05/31 | 3,764 | 3,791 | 3,737 | 3,755 | -60 | -1.6% | 10,710,800 |
2023/05/30 | 3,799 | 3,840 | 3,758 | 3,815 | +9 | +0.2% | 2,774,700 |
2023/05/29 | 3,783 | 3,823 | 3,765 | 3,806 | +53 | +1.4% | 3,155,800 |
2023/05/26 | 3,753 | 3,757 | 3,725 | 3,753 | -7 | -0.2% | 2,655,000 |
2023/05/25 | 3,728 | 3,764 | 3,706 | 3,760 | +8 | +0.2% | 3,052,600 |
2023/05/24 | 3,721 | 3,772 | 3,704 | 3,752 | +10 | +0.3% | 2,437,700 |
2023/05/23 | 3,734 | 3,758 | 3,692 | 3,742 | +41 | +1.1% | 3,115,700 |
2023/05/22 | 3,607 | 3,707 | 3,601 | 3,701 | +94 | +2.6% | 2,801,400 |
2023/05/19 | 3,620 | 3,622 | 3,588 | 3,607 | +19 | +0.5% | 1,994,000 |
2023/05/18 | 3,594 | 3,613 | 3,585 | 3,588 | -3 | -0.1% | 1,914,700 |
2023/05/17 | 3,614 | 3,621 | 3,581 | 3,591 | -37 | -1% | 2,115,100 |
2023/05/16 | 3,633 | 3,638 | 3,614 | 3,628 | +15 | +0.4% | 2,051,000 |
2023/05/15 | 3,592 | 3,616 | 3,580 | 3,613 | +38 | +1.1% | 1,525,300 |
2023/05/12 | 3,558 | 3,589 | 3,548 | 3,575 | +43 | +1.2% | 2,407,600 |
2023/05/11 | 3,545 | 3,554 | 3,522 | 3,532 | -46 | -1.3% | 1,623,600 |
2023/05/10 | 3,598 | 3,604 | 3,578 | 3,578 | -40 | -1.1% | 1,565,500 |
2023/05/09 | 3,562 | 3,622 | 3,562 | 3,618 | +30 | +0.8% | 2,232,600 |
2023/05/08 | 3,601 | 3,634 | 3,578 | 3,588 | -15 | -0.4% | 2,188,800 |
2023/05/02 | 3,585 | 3,630 | 3,563 | 3,603 | +61 | +1.7% | 2,318,800 |
2023/05/01 | 3,519 | 3,552 | 3,515 | 3,542 | +38 | +1.1% | 2,034,000 |
2023/04/28 | 3,493 | 3,554 | 3,479 | 3,504 | +75 | +2.2% | 3,791,600 |
2023/04/27 | 3,391 | 3,429 | 3,380 | 3,429 | +14 | +0.4% | 1,714,500 |
2023/04/26 | 3,437 | 3,445 | 3,395 | 3,415 | -26 | -0.8% | 1,868,000 |
2023/04/25 | 3,433 | 3,449 | 3,421 | 3,441 | +44 | +1.3% | 2,373,900 |
2023/04/24 | 3,363 | 3,427 | 3,351 | 3,397 | +115 | +3.5% | 3,249,400 |
2023/04/21 | 3,249 | 3,290 | 3,241 | 3,282 | +14 | +0.4% | 1,714,800 |
2023/04/20 | 3,305 | 3,310 | 3,265 | 3,268 | -51 | -1.5% | 2,382,600 |
2023/04/19 | 3,329 | 3,345 | 3,306 | 3,319 | -32 | -1% | 2,098,800 |
2023/04/18 | 3,340 | 3,351 | 3,328 | 3,351 | +33 | +1% | 1,746,200 |
451~
500
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム